Overview
What the PCP Needs to Know About IPF: From Diagnosis to Referral
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
In this activity, pulmonologist Gregory Cosgrove, MD, discusses the signs and symptoms of IPF to help PCP learners identify at-risk patients and achieve goals of earlier referral and treatment initiation, ultimately improving patient quality of life. The activity also features an animated whiteboard to illustrate take-home points for the PCP audience.
This activity is intended for PCPs and other community-based practitioners who may encounter at-risk patients who should be assessed for IPF and/or referred to specialty ILD care center.
Clinicians require education surrounding appropriate identification of IPF patients, implications of guidelines to practice, and the value of referral to a specialist. This activity is designed to provide practical guidance from an expert faculty to help increase awareness of signs and symptoms of IPF, and current and emerging treatment options, in order to optimize patient care across a multidisciplinary team.
Upon completion of this activity, participants will be able to:
• Outline risk factors associated with IPF
• Interpret findings from the steps in a differential diagnosis of IPF
• Describe comprehensive care plans for patients with IPF
• Discuss the role of primary care providers in the diagnosis and management of IPF
• Outline risk factors associated with IPF
• Interpret findings from the steps in a differential diagnosis of IPF
• Describe comprehensive care plans for patients with IPF
• Discuss the role of primary care providers in the diagnosis and management of IPF
Supported by an educational grant from Genentech, a member of the Roche Group.
1. If Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Gregory P. Cosgrove, MD, FCCP
Associate Professor
National Jewish Health & University of Colorado-Denver
Chief Medical Officer
Pulmonary Fibrosis Foundation
Denver, CO
Associate Professor
National Jewish Health & University of Colorado-Denver
Chief Medical Officer
Pulmonary Fibrosis Foundation
Denver, CO
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.
The following financial relationships have been provided:
Gregory P. Cosgrove, MD, FCCP (Faculty)
Grants/Research Support recipient: Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Global Blood Therapeutics
Advisor or Review Panel member: Boehringer Ingelheim, Genentech, Global Blood Therapeutics
Consultant (Occasional): Boehringer Ingelheim, Genentech, Global Blood Therapeutics
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 45 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 80% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Laurie Novoryta at Lnovoryta@achlcme.org.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.